Cardlytics - CDLX Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CDLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDLX, but not buy additional shares or sell existing shares.
View CDLX analyst ratings or view top-rated stocks.

5 equities research analysts have issued twelve-month price targets for Cardlytics' stock. Their CDLX share price forecasts range from $14.00 to $35.00. On average, they predict the company's share price to reach $20.40 in the next twelve months. This suggests a possible upside of 21.7% from the stock's current price.
View analysts price targets for CDLX or view top-rated stocks among Wall Street analysts.

Cardlytics' stock was trading at $66.09 at the beginning of the year. Since then, CDLX stock has decreased by 74.6% and is now trading at $16.76.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our CDLX earnings forecast.

Cardlytics, Inc. (NASDAQ:CDLX) issued its quarterly earnings data on Tuesday, May, 4th. The company reported ($0.34) EPS for the quarter, topping analysts' consensus estimates of ($0.56) by $0.22. The firm earned $53 million during the quarter, compared to the consensus estimate of $51.96 million. Cardlytics had a negative net margin of 50.15% and a negative trailing twelve-month return on equity of 15.46%. The company's revenue was up 16.5% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.26) earnings per share.
Read the conference call transcript.

Cardlytics issued an update on its second quarter 2022 earnings guidance on Wednesday, August, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $74.50 million-$76.50 million, compared to the consensus revenue estimate of $76.99 million.

26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com. Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO).

(CDLX) raised $76 million in an initial public offering on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

Cardlytics' stock is owned by many different institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (3.47%), JS Capital Management LLC (2.45%), Jennison Associates LLC (2.16%), State Street Corp (2.01%), Assenagon Asset Management S.A. (1.13%) and Northern Trust Corp (0.93%). Insiders that own company stock include Aimia Inc, Andrew Christiansen, Bryce Youngren, Clifford Sosin, David Leslie Adams, David Thomas Evans, John L Jr Klinck, John V Balen, John V Balen, Kirk Somers, Lynne Marie Laube, Mark A Johnson, S Aimee Lapic, Scott D Grimes, Scott D Grimes and Tony Weisman.
View institutional ownership trends.

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CDLX stock can currently be purchased for approximately $16.76.

Cardlytics (NASDAQ:CDLX) has a market capitalization of $551.24 million and generates $267.12 million in revenue each year. The company earns $-128,570,000.00 in net income (profit) each year or ($4.56) on an earnings per share basis.

The company employs 591 workers across the globe.

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The official website for the company is www.cardlytics.com. The company can be reached via phone at (888) 798-5802 or via email at ir@cardlytics.com.